• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Mini-thoracotomy in redo mitral valve surgery: safety and efficacy of a standardized procedure
CONCLUSIONS: Minimally invasive mitral valve redo surgery is a safe procedure. Less invasive techniques in redo surgery could minimize morbidity and mortality without prolonging the duration of CPB.PMID:34659803 | PMC:PMC8482333 | DOI:10.21037/jtd-21-667
Source: Journal of Thoracic Disease - October 18, 2021 Category: Respiratory Medicine Authors: Filippo Prestipino Riccardo D'Ascoli Ádám Nagy Gianluca Paternoster Erica Manzan Giampaolo Luzi Source Type: research

Colchicine and the combination of rivaroxaban and aspirin in patients hospitalised with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial
Lancet Respir Med. 2022 Oct 10:S2213-2600(22)00298-3. doi: 10.1016/S2213-2600(22)00298-3. Online ahead of print.ABSTRACTBACKGROUND: COVID-19 disease is accompanied by a dysregulated immune response and hypercoagulability. The Anti-Coronavirus Therapies (ACT) inpatient trial aimed to evaluate anti-inflammatory therapy with colchicine and antithrombotic therapy with the combination of rivaroxaban and aspirin for prevention of disease progression in patients hospitalised with COVID-19.METHODS: The ACT inpatient, open-label, 2 × 2 factorial, randomised, controlled trial was done at 62 clinical centres in 11 countries. Patient...
Source: Respiratory Care - October 13, 2022 Category: Respiratory Medicine Authors: John W Eikelboom Sanjit S Jolly Emilie P Belley-Cote Richard P Whitlock Sumathy Rangarajan Lizhen Xu Laura Heenan Shrikant I Bangdiwala Maria Luz Diaz Rafael Diaz Afzalhussein Yusufali Sanjib Kumar Sharma Wadea M Tarhuni Mohamed Hassany Alvaro Avezum Will Source Type: research

Ninety-seven cases of experiences with the left thoracotomy approach for off-pump conventional revascularization: a retrospective cohort study
CONCLUSIONS: Left thoracotomy for conventional revascularization is a safe procedure for appropriately selected patients, with few early complications and good early and mid-term results. More cases are ongoing and long-term results are in observation.PMID:36389332 | PMC:PMC9641355 | DOI:10.21037/jtd-22-1162
Source: Journal of Thoracic Disease - November 17, 2022 Category: Respiratory Medicine Authors: Dongyan Yang Kai Zhang Junshan Li Dong Wei Jing Ma Yulong Wang Yin Yang Jinghui Li Yunpeng Bai Yuhui Zhang Jing Gao Lianqun Wang Source Type: research

Hereditary hemorrhagic telangiectasia
Rev Mal Respir. 2023 Apr 14:S0761-8425(23)00136-5. doi: 10.1016/j.rmr.2023.02.007. Online ahead of print.ABSTRACTHereditary hemorrhagic telangiectasia, also known as Rendu-Osler - Weber disease, is a rare, autosomal dominant vascular disease, with prevalence of 1/5,000. The condition is characterized by muco-cutaneous telangiectasias, which are responsible for a hemorrhagic syndrome of variable severity, as well as arteriovenous malformations (AVMs) appearing in the lungs, the liver, and the nervous system. They can be the source of shunts, which may be associated with high morbidity (neurological ischemic stroke, brain ab...
Source: Revue des Maladies Respiratoires - April 16, 2023 Category: Respiratory Medicine Authors: A Parrot M Barral X Amiot C Bachmeyer I Wagner M Eyries S Alamowitch S Ederhy R Epaud S Dupuis-Girod J Cadranel Source Type: research

Pages: 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18